University of Texas-MD Anderson Cancer Center: Discovery Shows How Difficult-to-Treat Prostate Cancer Evades Immune System
July 19, 2019
July 19, 2019
HOUSTON, Texas, July 19 [TNSmedicalresearch] -- The University of Texas's MD Anderson Cancer Center issued the following news release:
* * *
- Study reports pre-clinical development of novel treatment and potential for combination use with immunotherapy drugs
* * *
Researchers at The University of Texas MD Anderson Cancer Center have discovered how an aggressive form of prostate cancer called double-negative prostate cancer (DNPC) metastasizes . . .
* * *
- Study reports pre-clinical development of novel treatment and potential for combination use with immunotherapy drugs
* * *
Researchers at The University of Texas MD Anderson Cancer Center have discovered how an aggressive form of prostate cancer called double-negative prostate cancer (DNPC) metastasizes . . .